Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Rajkumar

Showing results (161-170 of 773) with videos related to

Pageof 78
Sort By:
Current Opinion in Nephrology and Hypertension|January 7, 2016
Spectrum of manifestations of monoclonal gammopathy-associated renal lesionsSanjeev Sethi, Fernando C Fervenza, S Vincent Rajkumar
American Journal of Hematology|November 18, 2015
Effective use of panobinostat in combination with other active agents in myeloma in a novel five-drug combination: Case report and interesting observationsArchana M Rajan, Francis K Buadi, Vincent Rajkumar
Mayo Clinic Proceedings|November 4, 2022
Failure to Launch: Why Some Generics Don't TakeCaleb J Scheckel, Aakash Desai, S Vincent Rajkumar
Mayo Clinic Proceedings|February 9, 2007
Cancer symposium for the practitioner: introduction to solid tumorsAlex A Adjei, S Vincent Rajkumar, Ayalew Tefferi
Blood Cancer Journal|May 29, 2026
Monoclonal gammopathy of clinical significance: a multisystem reviewManraj Singh Sra, S Vincent Rajkumar, Shaji Kumar
Mayo Clinic Proceedings|October 2, 2010
Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidenceS Vincent Rajkumar, Robert A Kyle, Francis K Buadi
Blood Reviews|March 21, 2007
Monoclonal gammopathy of undetermined significance and smoldering multiple myelomaS Vincent Rajkumar, Martha Q Lacy, Robert A Kyle
Mayo Clinic Proceedings|August 6, 2020
Clinical Trial End Points in Severe COVID-19Aakash Desai, Amit Kulkarni, S Vincent Rajkumar, et al.
Blood|December 28, 2018
Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timingShaji K Kumar, Francis K Buadi, S Vincent Rajkumar
Mayo Clinic Proceedings|March 6, 2017
Call for Papers on Clinical Practice GuidelinesTom D Thacher, S Vincent Rajkumar, William L Lanier
Pageof 78

Showing results (161-170 of 773) with videos related to

Sort By:
Pageof 78
Current Opinion in Nephrology and Hypertension|January 7, 2016
Spectrum of manifestations of monoclonal gammopathy-associated renal lesionsSanjeev Sethi, Fernando C Fervenza, S Vincent Rajkumar
American Journal of Hematology|November 18, 2015
Effective use of panobinostat in combination with other active agents in myeloma in a novel five-drug combination: Case report and interesting observationsArchana M Rajan, Francis K Buadi, Vincent Rajkumar
Mayo Clinic Proceedings|November 4, 2022
Failure to Launch: Why Some Generics Don't TakeCaleb J Scheckel, Aakash Desai, S Vincent Rajkumar
Mayo Clinic Proceedings|February 9, 2007
Cancer symposium for the practitioner: introduction to solid tumorsAlex A Adjei, S Vincent Rajkumar, Ayalew Tefferi
Blood Cancer Journal|May 29, 2026
Monoclonal gammopathy of clinical significance: a multisystem reviewManraj Singh Sra, S Vincent Rajkumar, Shaji Kumar
Mayo Clinic Proceedings|October 2, 2010
Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidenceS Vincent Rajkumar, Robert A Kyle, Francis K Buadi
Blood Reviews|March 21, 2007
Monoclonal gammopathy of undetermined significance and smoldering multiple myelomaS Vincent Rajkumar, Martha Q Lacy, Robert A Kyle
Mayo Clinic Proceedings|August 6, 2020
Clinical Trial End Points in Severe COVID-19Aakash Desai, Amit Kulkarni, S Vincent Rajkumar, et al.
Blood|December 28, 2018
Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timingShaji K Kumar, Francis K Buadi, S Vincent Rajkumar
Mayo Clinic Proceedings|March 6, 2017
Call for Papers on Clinical Practice GuidelinesTom D Thacher, S Vincent Rajkumar, William L Lanier
Pageof 78